Transplantation: The promise of co-stimulatory blockade in transplantation.

about

Transplantation: The promise of co-stimulatory blockade in transplantation.

Item

http://www.wikidata.org/entity/Q44146444

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Transplantation: The promise of co-stimulatory blockade in transplantation.

@en

Transplantation: The promise of co-stimulatory blockade in transplantation.

@nl

type

Item

label

Transplantation: The promise of co-stimulatory blockade in transplantation.

@en

Transplantation: The promise of co-stimulatory blockade in transplantation.

@nl

prefLabel

Transplantation: The promise of co-stimulatory blockade in transplantation.

@en

Transplantation: The promise of co-stimulatory blockade in transplantation.

@nl

P1476

Transplantation: The promise of co-stimulatory blockade in transplantation.

@en

P2093

Jonathan S Bromberg

http://www.w3.org/2001/XMLSchema#string

Rolf N Barth

http://www.w3.org/2001/XMLSchema#string

P2860

Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion.

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naïve recipients

Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy

Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells.

Deciphering antibody-mediated rejection: new insights into mechanisms and treatment.

Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients.

Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties.

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

P2888

nrneph.2013.37

P304

189-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRNEPH.2013.37

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23458927

http://www.w3.org/2001/XMLSchema#string